Advertisement

Topics

Besponsa (Inotuzumab Ozogamicin) Approved for Deadly Blood Cancer

10:08 EDT 17 Aug 2017 | Drugs.com

THURSDAY, Aug. 17, 2017 -- The U.S. Food and Drug Adminstration on Thursday approved the anti-cancer drug Besponsa (inotuzumab ozogamicin) to treat B-cell acute lymphoblastic leukemia (ALL). B-cell ALL is a rapidly growing cancer that occurs when...

Original Article: Besponsa (Inotuzumab Ozogamicin) Approved for Deadly Blood Cancer

NEXT ARTICLE

More From BioPortfolio on "Besponsa (Inotuzumab Ozogamicin) Approved for Deadly Blood Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...